SSSutro Biopharma, Inc.
0.8578USDR
+0.0102+1.20%
At close at Aug 22, 22:56 GMT
USD
No trades
Price target
2.47RUSD+1.6089+187.56%
The 6 analysts offering 1 year price forecasts for Sutro Biopharma, Inc. have a max estimate of 5.00 and a min estimate of 0.8000.
Analyst rating
Based on 9 analysts giving stock ratings to Sutro Biopharma, Inc. in the past 3 months.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong buy
4
Buy
0
Hold
4
Sell
1
Strong sell
0
EPS
Forecast
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Q2 '26
−1.00
−0.50
0.00
0.50
1.00
Reported
Estimate
Currency: USD
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Q2 '26
Reported
0.52
−0.95
−0.59
−0.59
−0.83
−0.91
−0.14
—
—
—
—
Estimate
−0.27
−0.92
−0.79
−0.73
−0.83
−0.64
−0.38
−0.42
−0.44
−0.42
−0.42
Surprise
+291.69%
−3.08%
+25.47%
+19.68%
+0.05%
−41.62%
+63.39%
—
—
—
—
Revenue
Forecast
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Q2 '26
0.00
30.00 M
60.00 M
90.00 M
120.00 M
Reported
Estimate
Currency: USD
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Q2 '26
Reported
113.73 M
13.01 M
25.71 M
8.52 M
14.80 M
17.40 M
63.74 M
—
—
—
—
Estimate
57.36 M
12.07 M
21.02 M
15.29 M
12.15 M
11.61 M
15.84 M
10.11 M
9.36 M
8.67 M
8.75 M
Surprise
+98.29%
+7.75%
+22.27%
−44.28%
+21.79%
+49.83%
+302.50%
—
—
—
—
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
STRO EPS for the last quarter is −0.14 USD despite the estimation of −0.38 USD. In the next quarter EPS is expected to reach −0.42 USD. Track more of Sutro Biopharma, Inc. financials and stay on top of what is up with the company.
In the next quarter Sutro Biopharma, Inc. revenue is expected to reach 10.11 M USD. Check out Sutro Biopharma, Inc. revenue and earnings and make informed decisions.
According to analysts, STRO price target is 2.47 USD with a max estimate of 5.00 USD and a min estimate of 0.80 USD. Check if this forecast comes true in a year, meanwhile watch Sutro Biopharma, Inc. stock price chart and keep track of the current situation with STRO news and stock market news.
We've gathered opinions of 9 analysts rating STRO stock in the past 3 months. After counting all points of view, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.